PRESCRIPTION DRUG INDUSTRY

EVALUATION

BY UNBIASED INDUSTRY EXPERTS

RxMarketSCIENCE is an Industry, Policy and Strategy Research, Analysis, Evaluation and Education firm specialized in the study of global business eco-system of prescription drugs. We are the unbiased experts of the prescription drug commerce eco-system. Our mission at RxMarketSCIENCE is to make our industry knowledge available for prescription drug industry practitioners, firms, investors and key stakeholders through our engagements and research services.

shutterstock_1119378269_Color_Edit_edite

INDUSTRY•POLICY•STRATEGY

ELEVATE

STRATEGIC INSIGHTS TO NEXT LEVEL

We believe that strategic decision-making requires the ability to research the problem and its potential solutions within its context. However, this requires deep and comprehensive industry knowledge first. RxMarketSCIENCE helps elevate your strategic insights and decision-making ability to the next level. Whether it is an Industry Development, Policy Change or Strategic Change, it helps to understand the deeper level underpinnings of the situation before you make any changes.

 

Derived from our consulting experience, industry expertise, ongoing studies and research, the insights we provide have been very valuable for our clients and customers. The minds behind RxMarketSCIENCE have been helping the following segments for more than a decade:

 

PRIVATE EQUITY FIRMS  

Brings industry expertise on your side. Helps make decisions based on deep industry knowledge and context.

MANAGEMENT CONSULTING FIRMS

Enhances the consulting teams’ capability and knowledge on-demand. Decreases learning curve for new consultants.

CORPORATE STRATEGY GROUPS

Brings outside perspectives and market experiments support and practice-oriented research skills.

NEW VENTURES

Accelerate the industry landscape knowledge and help bring new solutions to market while minimizing market iteration.

 

INVESTMENT FIRMS

Helps de-code industry developments, strategy maneuvers by industry firms and policy changes. Decreases the learning cycle for new associates.

Skyscrapers
Image by Ansia Lasa

FOCUS

ON THE DOMAINS THAT DRIVE THE BUSINESS OF MEDICINES

Through our experience and studies , we found 4 main domains every stakeholder must deeply understand as they make strategic decisions. RxMarketSCIENCE helps clients navigate through these domains.  

american-government-building.png

REGULATORY POLICY

How does the government policy and regulations impact the industry dynamics

dynamic-arrow.png

INDUSTRY DYNAMICS

How does the industry's evolutionary dynamics affect competitive strategy and affect the positioning of companies

idea.png

COMPETITIVE STRATEGY

What is the true merit of competitive strategy employed or communicated by the industry players? 

002-project-management.png

TECHNOLOGY INNOVATIONS

How new technologies and innovative services can affect the industry eco-system

LEVERAGE

THE EXPERTISE ON SYSTEMIC AND INTER-SEGMENT ISSUES

We never stop learning.  We believe that systemic industry expertise is a must for a good strategist in the prescription drug industry eco-system. We also know it is hard for an expert in one firm to learn other segments within the industry. Hence we focus on broader and deeper expertise building in the end-to-end drug commerce system in order to help our clients. Our clients rely on our advice, positions and opinions on the major decisions they make.

GLOBAL & DOMESTIC DRUG COMMERCE SYSTEM & ITS ECONOMICS

Our focus is the global drug commerce system in between the drug/ingredients manufacturer and the patient. We study the flow of money, product and information (and their economics) between the patients and drug/ingredient manufacturers.

DRUG BENEFIT, ACCESS AND PAYMENTS SEGMENTS

Drug benefit, access and payment decisions indirectly or directly control many other aspects of the US drug commerce system. No major decisions on this industry can be made without clearly understanding these three aspects of the industry.

Rx TECHNOLOGIES, DATA & INFORMATICS SEGMENTS

Technology, data and informatics makes everything happen in this industry. With the new developments in data science and artificial intelligence, the new game business models of this segment is set to transform the way many things happen in the drug industry.

PHARMACEUTICAL CARE & OUTCOMES MANAGEMENT SEGMENTS

The topic of business of medicines is not complete without the considering the business of drug outcomes. Ultimately, from a societal perspective, the goal the business of medicines is to improve outcomes

Analyzing Graphs
shutterstock_1213401454_newjpg_edited.jp

AUTHENTIC . UNBIASED . TRUSTED